A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
University of Alabama at Birmingham
Soligenix
Prescient Therapeutics, Ltd.